What is the recommended treatment for herpes gladiatorum in a healthy adolescent or adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Herpes Gladiatorum Treatment

For a healthy adolescent or adult with herpes gladiatorum, treat with oral valacyclovir 1000 mg once daily for prophylaxis during wrestling season, or valacyclovir 500 mg twice daily for 7 days to treat acute outbreaks.

Understanding Herpes Gladiatorum

Herpes gladiatorum is HSV-1 infection transmitted through skin-to-skin contact during contact sports, primarily wrestling. Unlike genital herpes (predominantly HSV-2), this is a cutaneous HSV-1 infection affecting athletes in close-contact sports.

Treatment Approach

For Acute Outbreaks (First Episode or Recurrence)

Valacyclovir 500 mg orally twice daily for 7 days is the most practical regimen based on wrestling-specific research 1. This reduces viral shedding duration by 21% and expedites clearance compared to placebo (6.43 days vs 8.14 days) 1.

Alternative regimens based on general HSV treatment guidelines include:

  • Acyclovir 400 mg orally 3 times daily for 5 days 2
  • Acyclovir 800 mg orally twice daily for 5 days 2
  • Famciclovir 125 mg orally twice daily for 5 days 2

Key timing consideration: Start medication within 24 hours of symptom onset for maximum benefit 1.

For Prophylaxis During Wrestling Season

Valacyclovir 1000 mg once daily throughout the competitive season is highly effective for athletes with recurrent herpes gladiatorum 3, 4.

The evidence strongly supports prophylaxis:

  • 89.5% reduction in individual outbreaks at 28-day wrestling camps 3
  • 84.7% overall decrease in outbreak probability 3
  • 100% suppression in athletes with >2 years disease history using valacyclovir 500 mg daily 4

For athletes with disease duration <2 years, use the higher dose (1000 mg daily), as they had breakthrough rates of 8% on 500 mg daily 4.

Isolation Requirements

Withhold from competition for 120 hours (5 days) minimum after starting treatment, per NCAA/NFHS guidelines 3. This is critical—failure to isolate infected wrestlers led to major outbreaks affecting multiple teams 5.

For primary outbreaks involving multiple exposed individuals, 8-day isolation with suspended competition contained spread in >90% of cases 5.

Clinical Algorithm

  1. Identify the clinical scenario:

    • First outbreak → Treat acutely + consider seasonal prophylaxis
    • Recurrent outbreak → Treat acutely + strongly recommend seasonal prophylaxis
    • Pre-season prevention → Prophylaxis for all athletes with HSV-1 history
  2. For acute treatment:

    • Start valacyclovir 500 mg BID within 24 hours of symptoms
    • Continue for 7 days
    • Isolate from contact sports for minimum 120 hours
  3. For seasonal prophylaxis:

    • Disease >2 years: Valacyclovir 500 mg daily acceptable
    • Disease <2 years: Valacyclovir 1000 mg daily preferred
    • Continue throughout competitive season

Important Caveats

Environmental transmission risk is lower than direct contact but HSV-1 can be detected on gym equipment and surfaces 6. Disinfection of shared equipment reduces exposure 6.

Asymptomatic viral shedding occurs even with prophylaxis, though at reduced rates 2. Athletes on suppressive therapy can still transmit infection, so maintain hygiene practices (showering before training, not sharing equipment, avoiding sparring with visible lesions) 6.

Genomic sequencing has confirmed local transmission within gyms, with independent introduction into different facilities 6. This underscores the importance of screening and prophylaxis at the team/gym level, not just individual treatment.

The general HSV guidelines 7, 2 focus on genital herpes and don't specifically address the unique epidemiology of contact sports transmission. The wrestling-specific research 3, 1, 4 provides the most relevant evidence for herpes gladiatorum management and demonstrates superior outcomes with sport-specific prophylaxis protocols.

References

Research

Valacyclovir to expedite the clearance of recurrent herpes gladiatorum.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 2005

Research

Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 2016

Research

The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.